Connect your AI

Bruker BRKR Biospin — Goodwill Purchase Accounting Adjustments

Similar metrics at other companies

WAT

WATBiosciences — Goodwill

$3.8B—

TEC

TECHDiagnostics And Spatial Biology — Goodwill Held For Sale Adjustment

-$1.12M—

MSIProducts and Systems Integration — Goodwill Purchase Accounting Adjustments

$9M—

TELIndustrial Solutions — Goodwill Purchase Accounting Adjustments

$14M—

BTSGPharmacy Solutions — Goodwill Purchase Accounting Adjustments

$0—

GNRCDomestic — Goodwill Purchase Accounting Adjustments

-$1.55M—

Other financials

Income statement

Revenue$823.4M+2.7%

Gross profit$379.8M-2.9%

Operating income$10.2M-67.9%

Net income$14.4M-17.2%

EPS (diluted)$0.02-81.8%

Balance sheet

Cash & equivalents$137.6M-26.7%

Total debt$1.7B-20.9%

Total equity$2.5B+34.6%

Total assets$6.1B+3.3%

Cash flow

Operating cash flow$71.2M+9.5%

CapEx$24.2M-6.9%

Free cash flow$47.0M+20.5%

Valuation

Market cap$8.71B-13.2%

Enterprise value$10.25B-14.9%

P/S2.5×-0.4×

Profitability

Gross margin45.3%-3.7pp

Operating margin1.3%-5.0pp

Net margin-0.6%-10.0pp

FCF margin1.5%-3.6pp

Returns & leverage

Return on equity-1%-21.2pp

Debt / equity0.7×-0.5×

Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.

The official record: Bruker’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's biospin — goodwill purchase accounting adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Bruker's biospin — goodwill purchase accounting adjustments?: Bruker (BRKR) reported biospin — goodwill purchase accounting adjustments of $0 in Q4 2025.
What does biospin — goodwill purchase accounting adjustments mean?: Adjustments made to the initial valuation of goodwill within the BioSpin segment during the measurement period following an acquisition. These typically arise from finalizing the fair value of assets acquired or liabilities assumed.